KATIE PLOURD: Open Payments
NPI 1013259506 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,199 in 72 payments from 13 companies in 2025. Trend: 2023 $1,168 · 2024 $1,451 · 2025 $1,199
Food & beverage: $1,199
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $339 |
| PFIZER INC. | 13 | $223 |
| Ardelyx, Inc. | 11 | $185 |
| Gilead Sciences, Inc. | 10 | $159 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $59 |
| Regeneron Healthcare Solutions, Inc. | 3 | $48 |
| Janssen Biotech, Inc. | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Madrigal Pharmaceuticals | 2 | $30 |
| EVOKE PHARMA, INC. | 1 | $22 |
Products named: IBSRELA, RINVOQ, XELJANZ, CREON, VELSIPITY, XIFAXAN, LINZESS, DUPIXENT.
Industry payments across AL — which companies pay providers there.
